[Phase II study of paclitaxel (BMS-181339) in patients with ovarian cancer by 3-hour intravenous infusion].
Noda K, Ikeda M, Kudo R, Nishiya I, Yajima A, Tanaka K, Kodama S, Takahashi T, Tokunaga A, Satoh I, Nozawa S, Taketani Y, Terashima Y, Isonishi S, Takeda Y, Nishijima M, Kuroshima Y, Fujii S, Izumi R, Tamaya T, Mori T, Okada H, Ogita S, Ozaki M, Hatae M, et al.
Noda K, et al. Among authors: takahashi t.
Gan To Kagaku Ryoho. 1996 Feb;23(3):317-25.
Gan To Kagaku Ryoho. 1996.
PMID: 8712825
Clinical Trial.
Japanese.